Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Mutational Profile and Copy Number Alterations of Follicular Lymphoma Patients with Different Clinical Behavior

Blood (2020) 136 (Supplement 1): 7–8.

https://doi.org/10.1182/blood-2020-140430

Published: 2020

Journal Articles

Clinical Impact of the Presence of a Diffuse Large B-Cell Lymphoma (DLBCL) Component in the Outcome of Untreated Patients with Follicular Lymphoma (FL)

Laura Magnano, MD, Ivan Dlouhy, MD, Olga Balagué, MD, Alfredo Rivas-Delgado, MD, Jordina Rovira, MD, Kennosuke Karube, MD PhD, Blanca Gonzalez, MD, Alejandra Martinez-Trillos, MD, Antonio Martínez, MD PhD, Julio Delgado, Eva Gine, Neus Villamor, MD PhD, Elias Campo, MD PhD, Armando Lopez-Guillermo

Blood (2016) 128 (22): 3043.

https://doi.org/10.1182/blood.V128.22.3043.3043

Published: 2016

Journal Articles

A Complementary Role of High Throughput Sequencing and Multiparameter Cytometry for Minimal Residual Disease (MRD) Detection in Chronic Lymphocytic Leukemia (CLL):an European Research Initiative (ERIC) Study

Andy Rawstron, PhD, Claudia Fazi, PhD, Neus Villamor, MD PhD, Julio Delgado, MD PhD, Remi Letestu, MD PhD, Florence Cymbalista, MD, Carlos Palacio, Francesc Bosch, MD PhD, Ruth M De Tute, MSc, Stuart Liptrot, David O'Brien, FAMLs, Martin Spacek, MD, PhD, Johan Dobber, Arnon P. Kater, MD PhD, Peter C Gambell, David A Westerman, MBBS, FRACP, FRCPA, Asha Soosapilla, Stephen P. Mulligan, MBBS, PhD FRACP, FRCPA, Gerard Lozanski, MD, Ke Lin, PhD, Andrew R Pettitt, MRCP, PhD, Gabi Brachtl, Alexander Egle, MD, David W Williamson, PhD, Catherine M Sanders, PhD, Harlan Robins, PhD, Justin Boysen, Tait D. Shanafelt, MD, Curtis A. Hanson, MD, Jeffrey L. Jorgensen, MD PhD, William G. Wierda, MD PhD, Constance Yuan, MD PhD, Maryalice Stetler-Stevenson, MD PhD, Laura Rassenti, PhD, H. Elizabeth Broome, MD, Thomas J. Kipps, MD PhD, Mathieu Hauwel, Iuri Marinov, Fiona E. Craig, MBBS, Nomdedeu Josep, Carol Moreno, MD, Olga Stehlikova, MSc., Michael Doubek, Sarka Pospisilova, Prof., Dr., PhD, Karl-Anton Kreuzer, MD, Michael Hallek, MD, Peter Hillmen, MBChB, PhD, Emili Montserrat, MD PhD, Paolo Ghia, MD

Blood (2014) 124 (21): 1976.

https://doi.org/10.1182/blood.V124.21.1976.1976

Published: 2014

Journal Articles

Risk of Central Nervous System (CNS) Involvement in Patients with Mantle Cell Lymphoma (MCL): Analysis of Clinico-Biological Factors in a Series of 283 Cases

Blood (2014) 124 (21): 1677.

https://doi.org/10.1182/blood.V124.21.1677.1677

Published: 2014

Journal Articles

Daratumumab, a Novel Anti-CD38 Monoclonal Antibody Shows Anti-Tumor Activity in CLL and hampers Leukemia-Microenvironment Interactions

Alba Matas-Céspedes, MS, Anna Vidal-Crespo, MS, Vanina Rodriguez, Julio Delgado, MD PhD, Neus Villamor, MD PhD, Gael Roue, PhD, Elías Campo, MD PhD, Dolors Colomer, PhD, Parul Doshi, PhD, Adrian Wiestner, MD PhD, Paul W.H.I. Parren, PhD, Jeroen Lammerts van Bueren, PhD, Patricia Pérez-Galán, PhD

Blood (2014) 124 (21): 4680.

https://doi.org/10.1182/blood.V124.21.4680.4680

Published: 2014

Journal Articles

Differential Distribution Of Recurrent Gene Mutations In Subsets Of Chronic Lymphocytic Leukemia Patients With Stereotyped B-Cell Receptors: Results From A Multicenter Project Of The European Research Initiative On CLL In A Series Of 2482 Cases

Blood (2013) 122 (21): 4113.

https://doi.org/10.1182/blood.V122.21.4113.4113

Published: 2013

Journal Articles

Initial Characteristics, Treatment and Prognosis Of Elderly (≥ 70 years) Patients With Chronic Lymphocytic Leukemia (CLL): An Analysis Of a Series Of 367 Cases

Tycho Baumann, MD, Julio Delgado, MD, PhD, Rodrigo Santacruz, MD, Alejandra Martínez-Trillos, MD, Cristina Royo, PhD, Alba Navarro, PhD, Magdalena Pinyol, PhD, María Rozman, MD, PhD, Cristina López, PhD, Neus Villamor, MD, PhD, Marta Aymerich, MD, PhD, Arturo Pereira, MD, PhD, Anna Carrió, PhD, Emili Montserrat, MD, PhD

Blood (2013) 122 (21): 4155.

https://doi.org/10.1182/blood.V122.21.4155.4155

Published: 2013

Journal Articles

Novel Gene Mutations In Chronic Lymphocytic Leukemia: Prevalence and Clinical Implications In A Series Of 3185 Cases - Initial Results From The European Research Initiative On CLL

Blood (2013) 122 (21): 1614.

https://doi.org/10.1182/blood.V122.21.1614.1614

Published: 2013

Journal Articles

Detailed Molecular Analysis of Patients with Chronic Lymphocytic Leukemia Carrying 17p Deletions Reveals Concurrent Abnormalities with Prognostic Impact

Julio Delgado, Itziar Salaverría, Eriong Lee, Laura Jiménez, Alba Navarro, Dolors Colomer, Ivan Dlouhy, Laura Conde, Alejandra Martinez-Trillos, Cristina Lopez, Neus Villamor, MD, PhD, Marta Aymerich, MD, PhD, María Rozman, Eva Giné, Dolors Costa, Anna Carrió, Armando López-Guillermo, Elías Campo, Sílvia Beà

Blood (2012) 120 (21): 4577.

https://doi.org/10.1182/blood.V120.21.4577.4577

Published: 2012

Journal Articles

The Multi-Kinase Inhibitor Sorafenib Blocks Migration, BCR Survival Signals, Protein Translation and Stroma-Mediated Bortezomib Resistance in Mantle Cell Lymphoma

Silvia Xargay-Torrent, BS, Monica López-Guerra, PhD, Ifigènia Saborit-Villarroya, PhD, Laia Rosich, BS, Alba Navarro, BS, Neus Villamor, MD, PhD, Marta Aymerich, MD, PhD, Patricia Perez-Galan, PhD, Gael Roue, PhD, Elias Campo, MD, PhD, Dolors Colomer, PhD

Blood (2012) 120 (21): 1647.

https://doi.org/10.1182/blood.V120.21.1647.1647

Published: 2012

Journal Articles

Prognostic Impact of the MRD Status After Induction Treatment with Rituximab Plus Fludarabine, Cyclophosphamide and Mitoxantrone (R-FCM) in Patients with Chronic Lymphocytic Leukemia Receiving Rituximab Maintenance Therapy

Pau Abrisqueta, MD, Neus Villamor, MD, PhD, María José Terol, MD, PhD, Eva González-Barca, MD, PhD, Marcos González, Christelle Ferrà, Eugenia Abella, Julio Delgado, Jose Antonio García-Marco, MD, PhD, Yolanda González, MD, Felix Carbonell, MD, PhD, Secundino Ferrer, Encarna Monzo, MD, Isidro Jarque, MD, Ana Muntanola, MD, Mireia Constants, Lourdes Escoda, Emili Montserrat, MD. PhD, Francesc Bosch, MD, PhD

Blood (2012) 120 (21): 3930.

https://doi.org/10.1182/blood.V120.21.3930.3930

Published: 2012

Journal Articles

Rituximab Maintenance In Patients with Chronic Lymphocytic Leukemia (CLL) After Upfront Treatment with Rituximab Plus Fludarabine, Cyclophosphamide, and Mitoxantrone (R-FCM): Final Results of a Multicenter Phase II Trial On Behalf of the Spanish CLL Study Group (GELLC)

Francesc Bosch, MD, PhD, Pau Abrisqueta, Neus Villamor, MD. PhD, María José Terol, MD, PhD, Eva González-Barca, MD, Marcos González, MD, Christelle Ferrà, Eugenia Abella, Julio Delgado, Jose A. Garcia-Marco, MD, PhD, Yolanda Gonzalez, Felix Carbonell, MD, Secundino Ferrer, Encarna Monzo, MD, Isidro Jarque, Ana Muntanola, Mireia Constants, Lourdes Escoda, Emili Montserrat, MD. PhD

Blood (2011) 118 (21): 293.

https://doi.org/10.1182/blood.V118.21.293.293

Published: 2011

Journal Articles

Initial Features and Outcome Are Similar in Patients with Lymphoplasmacytic Lymphoma Regardless They Meet or Not Criteria of Waldenström Macroglobulinemia,

Eva Giné, MD, Jordina Rovira, MD, Alejandra Martinez-Trillos, MD, Neus Villamor, MD. PhD, Antonio Martinez, MD, Gonzalo Gutierrez-Garcia, MD, Luis Colomo, MD, Julio Delgado, MD, Tycho Stephan Baumann, MD, Elias Campo, MD, María Rozman, Armando Lopez-Guillermo, MD

Blood (2011) 118 (21): 3677.

https://doi.org/10.1182/blood.V118.21.3677.3677

Published: 2011

Journal Articles

Different Clinical Features but Not Outcome in SLL Patients Compared to CLL,

Alejandra Martinez-Trillos, MD, Eva Gine, MD, Jordina Rovira, MD, Marcos González, MD, Maria Jose Terol, MD, Julio Delgado, MD, Maria Rozman, MD, PhD, Martha Aymerich, MD, Elias Campo, MD, Armando Lopez-Guillermo, MD, Neus Villamor, MD. PhD

Blood (2011) 118 (21): 3896.

https://doi.org/10.1182/blood.V118.21.3896.3896

Published: 2011

Journal Articles

Chemoimmunotherapy Improves Survival of Patients with Chronic Lymphocytic Leukemia,

Gabriela Ghita, MD, Julio Delgado, MD. PhD, Tycho Baumann, MD, Ivan Dlouhy, MD, Marta Aymerich, MD. PhD, Dolors Colomer, MD. PhD, María Rozman, Neus Villamor, MD. PhD, Natalia Creus, MD. PhD, Arturo Pereira, MD. PhD, Emili Montserrat, MD. PhD

Blood (2011) 118 (21): 3908.

https://doi.org/10.1182/blood.V118.21.3908.3908

Published: 2011

Journal Articles

ZAP-70 Enhances BCR Signaling and Migration of Malignant B Lymphocytes towards CCL21 Via Induction of CCR7 Expression

Eva Calpe, Maria Joao Baptista, MSc, Carles Codony, PhD, Neus Villamor, MD, PhD, Pau Abrisqueta, MD, Olga Salamero, MD, Pere Barba, MD, Mercedes Gironella, MD, Noelia Purroy, MD, Marta Crespo, PhD, Francesc Bosch, MD, PhD

Blood (2010) 116 (21): 3591.

https://doi.org/10.1182/blood.V116.21.3591.3591

Published: 2010

Journal Articles

Changes in the Natural History, Treatment Modalities, and Survival Patterns in Patients with Chronic Lymphocytic Leukemia (CLL) from 1980 to 2008. The Hospital Clinic of Barcelona Experience

Pau Abrisqueta, MD, Francesc Bosch, MD, PhD, Marta Aymerich, MD, PhD, Eva Gine, MD, Carol Moreno, MD, PhD, Maria Rozman, MD, PhD, Neus Villamor, MD, PhD, Elias Campo, MD, PhD, Ciril Rozman, MD, PhD, Emili Montserrat, MD, PhD

Blood (2008) 112 (11): 48.

https://doi.org/10.1182/blood.V112.11.48.48

Published: 2008

Journal Articles

Rituximab, Fludarabine, Cyclophosphamide, and Mitoxantrone (R-FCM) Is a Highly Active Chemoimmunotherapy Regimen for Chronic Lymphocytic Leukemia.

Francesc Bosch, MD, PhD, Pau Abrisqueta, MD, Neus Villamor, MD, PhD, Maria Jose Terol, MD, Josep-Maria Ribera, MD, Eva Gonzalez-Barca, MD, Marcos Gonzalez, MD, Eugenia Abella, MD, Julio Delgado, MD, Yolanda Gonzalez, MD, Secundino Ferrer, MD, Felix Carbonell, MD, Lourdes Escoda, MD, Isidro Jarque, MD, Encarnacion Monzo, MD, Ana Muntañola, MD, Olga Salamero, MD, Emili Montserrat, MD

Blood (2008) 112 (11): 2097.

https://doi.org/10.1182/blood.V112.11.2097.2097

Published: 2008

Journal Articles

BCL-2 Phosphorylation Modulates Sensitivity to the BH3-Mimetic GX15-070 (Obatoclax) and Reduces Its Synergistic Interaction with Bortezomib in Chronic Lymphocytic Leukemia Cells.

Patricia Perez Galan, PhD, Gael Roue, PhD, Monica Lopez Guerra, BS, Neus Villamor, MD, PhD, Emili Montserrat, MD, PhD, Elias Campo, MD, PhD, Dolors Colomer, PhD

Blood (2007) 110 (11): 3464.

https://doi.org/10.1182/blood.V110.11.3464.3464

Published: 2007

Journal Articles

Selective Inhibition of I kappaB Kinase Sensitizes Mantle Cell Lymphoma B Cells to TRAIL by Decreasing c-FLIP Level.

Gaël Roué, PhD, Patricia Pérez-Galán, PhD, Mónica López-Guerra, BS, Neus Villamor, MD, PhD, Elias Campo, MD, PhD, Dolors Colomer, PhD

Blood (2006) 108 (11): 258.

https://doi.org/10.1182/blood.V108.11.258.258

Published: 2006

NARROW

Mutational Profile and Copy Number Alterations of Follicular Lymphoma Patients with Different Clinical Behavior

Clinical Impact of the Presence of a Diffuse Large B-Cell Lymphoma (DLBCL) Component in the Outcome of Untreated Patients with Follicular Lymphoma (FL)

A Complementary Role of High Throughput Sequencing and Multiparameter Cytometry for Minimal Residual Disease (MRD) Detection in Chronic Lymphocytic Leukemia (CLL):an European Research Initiative (ERIC) Study

Risk of Central Nervous System (CNS) Involvement in Patients with Mantle Cell Lymphoma (MCL): Analysis of Clinico-Biological Factors in a Series of 283 Cases

Daratumumab, a Novel Anti-CD38 Monoclonal Antibody Shows Anti-Tumor Activity in CLL and hampers Leukemia-Microenvironment Interactions

Differential Distribution Of Recurrent Gene Mutations In Subsets Of Chronic Lymphocytic Leukemia Patients With Stereotyped B-Cell Receptors: Results From A Multicenter Project Of The European Research Initiative On CLL In A Series Of 2482 Cases

Initial Characteristics, Treatment and Prognosis Of Elderly (≥ 70 years) Patients With Chronic Lymphocytic Leukemia (CLL): An Analysis Of a Series Of 367 Cases

Novel Gene Mutations In Chronic Lymphocytic Leukemia: Prevalence and Clinical Implications In A Series Of 3185 Cases - Initial Results From The European Research Initiative On CLL

Detailed Molecular Analysis of Patients with Chronic Lymphocytic Leukemia Carrying 17p Deletions Reveals Concurrent Abnormalities with Prognostic Impact

The Multi-Kinase Inhibitor Sorafenib Blocks Migration, BCR Survival Signals, Protein Translation and Stroma-Mediated Bortezomib Resistance in Mantle Cell Lymphoma

Prognostic Impact of the MRD Status After Induction Treatment with Rituximab Plus Fludarabine, Cyclophosphamide and Mitoxantrone (R-FCM) in Patients with Chronic Lymphocytic Leukemia Receiving Rituximab Maintenance Therapy

Rituximab Maintenance In Patients with Chronic Lymphocytic Leukemia (CLL) After Upfront Treatment with Rituximab Plus Fludarabine, Cyclophosphamide, and Mitoxantrone (R-FCM): Final Results of a Multicenter Phase II Trial On Behalf of the Spanish CLL Study Group (GELLC)

Initial Features and Outcome Are Similar in Patients with Lymphoplasmacytic Lymphoma Regardless They Meet or Not Criteria of Waldenström Macroglobulinemia,

Different Clinical Features but Not Outcome in SLL Patients Compared to CLL,

Chemoimmunotherapy Improves Survival of Patients with Chronic Lymphocytic Leukemia,

ZAP-70 Enhances BCR Signaling and Migration of Malignant B Lymphocytes towards CCL21 Via Induction of CCR7 Expression

Changes in the Natural History, Treatment Modalities, and Survival Patterns in Patients with Chronic Lymphocytic Leukemia (CLL) from 1980 to 2008. The Hospital Clinic of Barcelona Experience

Rituximab, Fludarabine, Cyclophosphamide, and Mitoxantrone (R-FCM) Is a Highly Active Chemoimmunotherapy Regimen for Chronic Lymphocytic Leukemia.

BCL-2 Phosphorylation Modulates Sensitivity to the BH3-Mimetic GX15-070 (Obatoclax) and Reduces Its Synergistic Interaction with Bortezomib in Chronic Lymphocytic Leukemia Cells.

Selective Inhibition of I kappaB Kinase Sensitizes Mantle Cell Lymphoma B Cells to TRAIL by Decreasing c-FLIP Level.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only